Journals / Turkish Journal of Hematology / 2002 / Cilt: 19 - Sayı: 2

The frequency and distribution pattern of B-thalassemia mutations in Turkey

Pages
309–315
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall frequency of ß-thalassemia is 2%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ß-thalassemia, a-thalassemia and sickle cell anemia are the three most common hemoglobinopathies in Turkey. ß-thalassemia major makes up 73%, sickle cell anemia 23% and Hb H disease 4% of total patients with hemoglobinopathy.
📊
Key Findings & Data:The overall frequency of ß-thalassemia is 2%.
💡
Conclusion & Impact:In Turkey, ß-thalassemia mutations are very heterogeneous although frequencies of these mutations show some regional differences there is no specific that ß-thalassemia mutation or distribution pattern that would aid in the identification of any ethnic background.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:alfa-Talasemi · beta-Talasemi · Mutasyon

Özet

ß-thalassemia, a-thalassemia and sickle cell anemia are the three most common hemoglobinopathies in Turkey. ß-thalassemia major makes up 73%, sickle cell anemia 23% and Hb H disease 4% of total patients with hemoglobinopathy. The overall frequency of ß-thalassemia is 2%. However, the frequency shows regional variations and in some areas it is as high as 13%. Molecular studies indicated the presence of more than 35 different mutations associated with ß-thalassemia. In this study it was shown that five different mutations, namely IVSI-110 (G-A), IVSI-6 (T-C), IVSII-1 (G-A), IVSII-745 (C-G) and IVSI-1 (G-A) make up 71% of all ß-thalassemia mutations. The rate of consanguineous marriage in families with thalassemia major is %63. However, in 11% of these families, parents carry two different thalassemia mutations. The IVSI-1 (GÆA) mutation is most prevalent in the Aegean Region and it seemed that this mutation moved from this region toward Marmara, Black Sea, Middle, East and South-eastern Anatolia. The IVSII-745 (C-G) is most prevalent in the Mediterranean region and it moved toward Central Anatolia, Black Sea and South-eastern Anatolia. Contrary to these two mutations FSC8 (-AA), IVSII-1 (G-A) and -30 (T-A) mutations are most prevalent in Eastern Anatolia and they moved from this region to South-eastern Anatolia, Mediterranean Region, Central Anatolia and Aegean Region. The frequency of various mutations in Central Anatolia is very close to the mean figures given for Turkey indicating that these mutations are well mixed in this region. Sickle cell anemia and sickle cell ß-thalassemia are almost exclusively seen in eastern coast of Mediterranean Sea and in Thrace. In Turkey, ß-thalassemia mutations are very heterogeneous although frequencies of these mutations show some regional differences there is no specific that ß-thalassemia mutation or distribution pattern that would aid in the identification of any ethnic background.

🔖

Cite This Article

ALTAY, Ç. (2002). The frequency and distribution pattern of B-thalassemia mutations in Turkey. Turkish Journal of Hematology, Cilt: 19 - Sayı: 2, 309–315. https://ajindex.com/articles/413426

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Altay Ç, Basak AN. Molecular basis and prenatal diagnosis of hemoglobinopathies in Turkey. Int J Pediatr Hematol Oncol 1995;2:283-90
  2. The results of Turkish Society of hemoglobinopathies. HI. National Congress of Pediatric Hematology, 17-20 October, 2001, Ankara, Turkey
  3. Öner R, Altay Ç, Gurgey A, Aksoy M, Kiline Y, Stoming TA, Reese AL, Kutlar A, Kutlar F, Huisman TH. ß-thalassemia in Turkey. Hemoglobin 1990;14:l-13
  4. Aulehla-Scholz C, Başaran S, Agaoglu L, Arcasoy A, Holzgreve W, Miny P, Ridolfi F, Horst J. Molecular basis of ß-thalassemia in Turkey: Detection of rare mutations by direct sequencing. Hum Genet 1990;84:195-7
  5. Diaz-Chico JC, Yang KG, Stoming TA, Efremov DG, Kutlar A, Kutlar F, Aksoy A, Altay C, Gurgey A, Kilinç Y, Huisman THJ. Mild and severe ß-thalassemia among homozygotes from Turkey: Identification of the types by hybridization of amplified DNA with synthetic probes. Blood, 1988;71:248-251
  6. Basak AN, Özçelik H, Özer A, Tolun A, Aksoy M, Agaoglu L, Ridolfi F, Ulukutlu L, Akar N, Gürgey A, Kirdar B. The molecular basis of ß-thalassemia in Turkey. Hum Genet 1992;89:315-8
  7. Gurgey A, Altay Ç, Diaz-Chico JC, Kutlar F, Kutlar A, Huisman TH. Molecular heterogeneity of ß-thalassemia intermedia in Turkey. Acta Haematol 1989;81:22-7
  8. Altay C, Gürgey A. ß-thalassemia in Turkey. Hematol Rev 1992;6:77-81
  9. Betke K, Marti HR, Schlicht I. Estimation of small percentages of foetal hemoglobin. Nature 1959; 184:1877-8
  10. Huisman THJ, Jonxis JHP. The hemoglobinopathies. Techniques of Identification: Clinical and Biochemical Analysis. New York: Marcel Dekker, 1977, Vol 6
  11. Old JM, Varawalla N, Weatherall DJ. Rapid detection and prenatal diagnosis of ß-thalassemia: Studies in Indian and Cyproit populations in the UK. Lancet 1990,336:834-6
  12. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-9
  13. Öner C, Gürgey A, Öner R, Balkan H, Gümrük F, Baysal E, Altay Ç. The molecular basis of HbH disease in Turkey. Hemoglobin 1997;21:41-51
  14. Akar N, Altay Ç, et al. The results of national hemoglobinopathy registry. XXV. National Congress of Hematology, 12-15 November, 1997, Istanbul, Turkey
  15. Weatherall DJ, Clegg JB. The Thalassemia Syndromes. 4th ed., Blackwell Scientific Publications, 2001 16. Huisman THJ, Carver MFH, Efremov GD. A Syllabus of Human Hemoglobin Variants 2nd ed. The Sickle Cell Anemia Foundation, Augusta, GA, 1998
  16. Altay C, Oner C, Oner R, Gu